Otero Jose Manuel 4
4 · Lexeo Therapeutics, Inc. · Filed Jun 14, 2024
Insider Transaction Report
Form 4
Otero Jose Manuel
Chief Operating Officer
Transactions
- Award
Common Stock
2024-06-12+31,250→ 31,250 total - Award
Stock Option (Right to Buy)
2024-06-12+187,500→ 187,500 totalExercise: $18.19Exp: 2034-06-11→ Common Stock (187,500 underlying)
Footnotes (2)
- [F1]The reported securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on August 15, 2025, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]25% of the shares underlying the option shall vest on May 20, 2025, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.